5.5: FDA Headquarters Consolidation

Provide a consolidated FDA headquarters campus to improve operations for employees.

Other Information:

The FDA is cooperating with the General Services Administration (GSA) to consolidate the agency's diverse headquarters components, now housed in over 40 different buildings all around the greater Washington, D.C., area, to a new campus at White Oak in Montgomery County, Md. This consolidation was initiated through the FDA Revitalization Act of 1990, and the FDA is now making it a reality. The new White Oak campus will begin housing employees in the coming year, and will house 1,700 FDA staff by 2005. There are four additional projects moving forward simultaneously at the White Oak campus, which together will eventually house a total of over 7,000 FDA employees in modern office and lab space. The first FDA employees will be arriving at White Oak this fall. The consolidation of FDA headquarters from 16 locations to three will offer many benefits: Support effective collaboration and coordination of the agency's growing and diverse expertise in the face of increasingly complex public health challenges Provide greater access to the public, as well as better security for agency personnel Improve the efficiency of agency operations substantially through: 1) standardized, modernized, and centralized document handling, 2) greater use of shared facilities such as libraries and conference areas, and 3) elimination of redundancies in a wide range of administrative management tasks Reduce management layers Provide more of a "critical mass" for the agency's ability to develop and conduct scientific activities, including analyses for efficient risk management and translational and regulatory research, to improve the scientific foundations and efficiency of the FDA's regulatory activities.

Indicator(s):

Indicator:1

Content